These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 671450)

  • 1. Piperazinylpyrazines with central serotoninmimetic activity.
    Lumma WC; Hartman RD; Saari WS; Engelhardt EL; Hirschmann R; Clineschmidt BV; Torchiana ML; Stone CA
    J Med Chem; 1978 Jun; 21(6):536-42. PubMed ID: 671450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-212: a serotonin-like agonist in the CNS.
    Clineschidmt BV
    Gen Pharmacol; 1979; 10(4):287-90. PubMed ID: 488663
    [No Abstract]   [Full Text] [Related]  

  • 3. Central serotonin-like activity of 6-chloro-2-[1-piperazinyl]-pyrazine (CPP; MK-212).
    Clineschmidt BV; Mcguffin JC; Pflueger AB
    Eur J Pharmacol; 1977 Jul; 44(1):65-74. PubMed ID: 885160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological differentiation of the central 5-hydroxytryptamine-like actions of MK-212 (6-chloro-2[1-piperazinyl]-pyrazine),p-methoxyamphetamine and fenfluramine in an in vivo model system.
    Clineschmidt BV; McGuffin JC
    Eur J Pharmacol; 1978 Aug; 50(4):369-75. PubMed ID: 151629
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioactive conformation of 1-arylpiperazines at central serotonin receptors.
    Huff JR; King SW; Saari WS; Springer JP; Martin GE; Williams M
    J Med Chem; 1985 Jul; 28(7):945-8. PubMed ID: 4009617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperazinylquinoxalines with central serotoninmimetic activity.
    Lumma WC; Hartman RD; Saari WS; Engelhardt EL; Lotti VJ; Stone CA
    J Med Chem; 1981 Jan; 24(1):93-101. PubMed ID: 6451700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines.
    Meurer LC; Tolman RL; Chapin EW; Saperstein R; Vicario PP; Zrada MM; MacCoss M
    J Med Chem; 1992 Oct; 35(21):3845-57. PubMed ID: 1359141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine).
    Clineschmidt BV; Totaro JA; Pflueger AB; McGuffin JC
    Pharmacol Res Commun; 1978 Mar; 10(3):219-28. PubMed ID: 684030
    [No Abstract]   [Full Text] [Related]  

  • 9. Central serotoninmimetic action of phenylpiperazines.
    Maj J; Lewandowska A
    Pol J Pharmacol Pharm; 1980; 32(4):495-504. PubMed ID: 7255267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
    Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
    Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract.
    Leonardi A; Guarneri L; Poggesi E; Angelico P; Velasco C; Cilia A; Testa R
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1027-37. PubMed ID: 11714892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
    Mensonides-Harsema MM; Liao Y; Böttcher H; Bartoszyk GD; Greiner HE; Harting J; de Boer P; Wikström HV
    J Med Chem; 2000 Feb; 43(3):432-9. PubMed ID: 10669570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationship studies of CNS agents, XV: N-[omega-(4-aryl-1-piperazinyl)alkyl]-2-oxo-1,2,3,4-tetrahydroquinoline s and -4-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indoles: new, highly potent 5-HT1A ligands.
    Mokrosz JL; Duszyńska B; Paluchowska MH
    Arch Pharm (Weinheim); 1994 Aug; 327(8):529-31. PubMed ID: 7944908
    [No Abstract]   [Full Text] [Related]  

  • 16. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.
    Ward JS; Merritt L; Klimkowski VJ; Lamb ML; Mitch CH; Bymaster FP; Sawyer B; Shannon HE; Olesen PH; Honoré T
    J Med Chem; 1992 Oct; 35(22):4011-9. PubMed ID: 1433209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization.
    Delagrange P; Emerit MB; Merahi N; Abraham C; Morain P; Rault S; Renard P; Pfeiffer B; Guardiola-Lemaître B; Hamon M
    Eur J Pharmacol; 1996 Dec; 316(2-3):195-203. PubMed ID: 8982686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.